UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosis
Bioscience Reports · 26.06.2024 · 44 (6)
DOI: 10.1042/bsr20232147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 14.06.2024. Verfasst von Amy Collins und 18 weiteren Autor:innen. Beteiligte Einrichtung: Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, U.K. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Liver Cirrhosis, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK (CRUK), North West Cancer Research (NWCR), Medical Research Council (MRC).
Abstract (Originalsprache)
Liver fibrosis is the excessive accumulation of extracellular matrix proteins that occurs in most types of chronic liver disease. At the cellular level, liver fibrosis is associated with the activation of hepatic stellate cells (HSCs) which transdifferentiate into a myofibroblast-like phenotype that is contractile, proliferative and profibrogenic. HSC transdifferentiation induces genome-wide changes in gene expression that enable the cell to adopt its profibrogenic functions. We have previously identified that the deubiquitinase ubiquitin C-terminal hydrolase 1 (UCHL1) is highly induced following HSC activation; however, the cellular targets of its deubiquitinating activity are poorly defined. Here, we describe a role for UCHL1 in regulating the levels and activity of hypoxia-inducible factor 1 (HIF1), an oxygen-sensitive transcription factor, during HSC activation and liver fibrosis. HIF1 is elevated during HSC activation and promotes the expression of profibrotic mediator HIF target genes. Increased HIF1α expression correlated with induction of UCHL1 mRNA and protein with HSC activation. Genetic deletion or chemical inhibition of UCHL1 impaired HIF activity through reduction of HIF1α levels. Furthermore, our mechanistic studies have shown that UCHL1 elevates HIF activity through specific cleavage of degradative ubiquitin chains, elevates levels of pro-fibrotic gene expression and increases proliferation rates. As we also show that UCHL1 inhibition blunts fibrogenesis in a pre-clinical 3D human liver slice model of fibrosis, these results demonstrate how small molecule inhibitors of DUBs can exert therapeutic effects through modulation of HIF transcription factors in liver disease. Furthermore, inhibition of HIF activity using UCHL1 inhibitors may represent a therapeutic opportunity with other HIF-related pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, U.K.
- FibroFind Ltd, FibroFind Laboratories, Medical School, Newcastle University, U.K.
- Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology University of Liverpool, U.K.
- Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, U.K.
- Department of HPB and Transplant Surgery, Freeman Hospital, Newcastle Upon Tyne, U.K.
Förderung
- Cancer Research UK (CRUK)
- North West Cancer Research (NWCR)
- Medical Research Council (MRC)
- North West Cancer Research/Mesothelioma UK
- Biotechnology and Biological Sciences Research Council (BBSRC)
- Worldwide Cancer Research (WCR)
Zitieren
APA
Collins, A., Scott, R., Wilson, C. L., Abbate, G., Ecclestone, G. B., Albanese, A. G., Biddles, D., White, S., French, J., Moir, J., Alrawashdeh, W., Wilson, C., Pandanaboyana, S., Hammond, J. S., Thakkar, R., Oakley, F., Mann, J., Mann, D. A., & Kenneth, N. S. (2024). UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosis. Bioscience Reports, 44(6). https://doi.org/10.1042/bsr20232147
Vancouver
Collins A, Scott R, Wilson CL, Abbate G, Ecclestone GB, Albanese AG, et al. UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosis. Bioscience Reports. 2024;44(6). doi:10.1042/bsr20232147
BibTeX
@article{Collins2024,
author = {Collins, Amy and Scott, Rebecca and Wilson, Caroline L and Abbate, Giuseppe and Ecclestone, Gabrielle B and Albanese, Adam G and Biddles, Demi and White, Steven and French, Jeremy and Moir, John and Alrawashdeh, Wasfi and Wilson, Colin and Pandanaboyana, Sanjay and Hammond, John S and Thakkar, Rohan and Oakley, Fiona and Mann, Jelena and Mann, Derek A and Kenneth, Niall S},
title = {UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosis},
journal = {Bioscience Reports},
year = {2024},
volume = {44},
number = {6},
doi = {10.1042/bsr20232147}
}
EUVIMED